FORMER GLAXOSMITHKLINE vice-president of finance Anne-Françoise Nesmes has joined international veterinary pharmaceuticals business Dechra Pharmaceuticals.
Nesmes has been with GSK since 1997, working in a variety of finance roles such as vice-president of finance of vaccines in Belgium and vice-president financial controller for Europe. During her time at the business, she gained experience in corporate planning, commercial finance and internal audit.
Prior to her role at GSK, Nesmes held finance roles with seals manufacturer John Crane, packaging business Tetra Pak, ADP and Caterpillar UK.
Mike Redmond, chairman of Dechra, said: "We are delighted that Anne-Françoise is joining Dechra. She is a high-calibre finance professional who also has valuable international, pharmaceutical, manufacturing and commercial experience. She will be a welcome addition to the executive team.
"I, and the rest of the board, look forward to working with Anne-Françoise to continue to progress our strategy of delivering a high-growth, cash-generative, specialist veterinary products business."
You may also like
If budgeting is to have any value at all, it needs a radical overhaul. In today's dynamic marketplace, budgeting can no longer serve as a company's only management system; it must integrate with and support dedicated strategy management systems, process improvement systems, and the like. In this paper, Professor Peter Horvath and Dr Ralf Sauter present what's wrong with the current approach to budgeting and how to fix it.
In this white paper CCH provide checklists to help accountants and finance professionals both in practice and in business examine these issues and make plans. Also includes a case study of a large commercial organisation working through the first year of mandatory iXBRL filing.